Hutch News
Results per Page:
New study reveals weakness in emerging type of aggressive prostate tumor
Tumors that turn off androgen receptor may have turned on new drug target
Overcoming androgen therapy resistance in prostate cancer
From the Peter Nelson Lab, Human Biology Division
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Tailoring treatment for prostate cancer
Hutchinson Center researchers and Duke University colleagues discover a genomic signature that may allow doctors to individualize therapy for men with metastatic prostate cancer
Research explains how advanced prostate cancer becomes resistant to androgen-deprivation therapy
Findings suggest androgen production occurs within metastatic prostate tumors